Prevalence and therapeutic intensity of dispensed drug groups for individuals with multiple medications: A register-based study of 2.2 million individuals

Journal of Pharmaceutical Health Services Research

Volumn 1, Issue 4, 2010, Pages 145-155

  Hovstadius, Bo ^a,b   Tågerud, Sven ^c   Petersson, Göran ^a   Åstrand, Bengt ^a  

^a LINNAEUS UNIVERSITY   (Sweden)

^b Mergers and Acquisitions Group   (Sweden)

^c School of Natural Sciences   (Sweden)

Author keywords

Aged; Drug therapy; Drug utilization; Polypharmacy; Prescription drugs; Registries

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; ANALGESIC AGENT; ANTIANEMIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC AGENT; CENTRAL STIMULANT AGENT; DIURETIC AGENT; LAXATIVE; MINERAL; PRESCRIPTION DRUG; PSYCHEDELIC AGENT; SEX HORMONE; VITAMIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DRUG USE; DRUG UTILIZATION; FEMALE; HUMAN; INDIVIDUAL BASED POPULATION MODEL; MALE; OUTPATIENT; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; PRIORITY JOURNAL; REGISTER; SEX DIFFERENCE; SWEDEN; THERAPY EFFECT;

EID: 79953733150     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/j.1759-8893.2010.00029.x     Document Type: Article

References (31)

1. Kaufman DW et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287: 337-344.
2. World Health Organization. Rational use of medicines by pre-scribers and patients. Report by the secretariat, in Executive Board 115th Session. Geneva: World Health Organization, 2004.
3. Salazar JA et al. Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 2007; 6: 695-704.
4. Gorard DA. Escalating polypharmacy. QJM 2006; 99: 797-800.
5. Haider SI et al. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002. Int J Clin Pharmacol Ther 2007; 45: 643-653.
6. Hajjar ER et al. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345-351.
7. Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Gen Intern Med 1993; 8: 278-283.
8. Bushardt RL, Jones KW. Nine key questions to address polyp-harmacy in the elderly. JAAPA 2005; 18: 32-37.
9. Bjerrum L et al. Methods for estimating the occurrence of polyp-harmacy by means of a prescription database. Eur J Clin Pharmacol 1997; 53: 7-11.
10. Bjerrum L et al. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 1998; 54: 197-202.
11. Wettermark B et al. The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007; 16: 726-735.
12. Swedish National Corporation of Pharmacies. [Swedish Drug Statistics Sales of medicines in Sweden 2006]. Swedish National Corporation of Pharmacies. 2007. www2.apoteket.se/NR/rdonlyres/0B1016AD-BCCF-47EF-B2AB-C0CE4AC0004E/0/Lakemedel2006.pdf (accessed 4 November 2010) [in Swedish].
13. Hovstadius B et al. Dispensed drugs and multiple medications in the Swedish population: an individual-based register study. BMC Clin Pharmacol 2009; 9: 11.
14. Hallas J. Drug utilization statistics for individual-level pharmacy dispensing data. Pharmacoepidemiol Drug Saf 2005; 14: 455- 463.
15. Rahimtoola H et al. Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy - a pilot study. Pharmacoepidemiol Drug Saf 2004; 13: 41-47.
16. SWEDRES 2006. A Report on Swedish Antibiotic Utilisation and Resistance in Human Medicine. Stockholm: Swedish Institute for Infections Disease Control, 2006.
17. Socialstyrelsen. [Indicators for evaluation of the quality in drug therapy for elderly]. Stockholm: Socialstyrelsen, 2003 [in Swedish].
18. Stovring H et al. Counting drugs to understand the disease: the case of measuring the diabetes epidemic. Popul Health Metr 2007; 5: 2.
19. Sartor F, Walckiers D. Estimate of disease prevalence using drug consumption data. Am J Epidemiol 1995; 141: 782-787.
20. Vanderpump MP et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55-68.
21. Pilote L et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007; 176: S1-44.
22. Blix HS et al. Age- and gender-specific antibacterial prescribing in Norway. J Antimicrob Chemother 2007; 59: 971-976.
23. Grigoriadis S, Robinson GE. Gender issues in depression. Ann Clin Psychiatry 2007; 19: 247-255.
24. Galdas PM et al. Men and health help-seeking behaviour: literature review. J Adv Nurs 2005; 49: 616-623.
25. Sundquist K et al. Increasing trends of obesity in Sweden between 1996/97 and 2000/01. Int J Obes Relat Metab Disord 2004; 28: 254-261.
26. Icen M et al. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol 2009; 60: 394-401.
27. Uttjek M et al. Psoriasis care consumption and expectations from a gender perspective in a psoriasis population in northern Sweden. Acta Derm Venereol 2005; 85: 503-508.
28. Nyberg F et al. 'The Laundry Bag Project' - unequal distribution of dermatological healthcare resources for male and female psoriatic patients in Sweden. Int J Dermatol 2008; 47: 144-149.
29. Statistiska centralbyrån. [Expected length of life 2003-2007]. Statistiska centralbyrån. www.scb.se/statistik/BE/BE0101/2007A01a/Be0101Livsl%c3%a4ngdstabeller_07.xls (accessed 18 March 2009) [in Swedish].
30. Steinman MA et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54: 1516-1523.
31. Haider SI et al. Analysis of the association between polypharmacy and socioeconomic position among elderly aged >/=77 years in Sweden. Clin Ther 2008; 30: 419-427.